295 related articles for article (PubMed ID: 16103622)
1. Decline of maternal hepatitis a antibodies during the first 2 years of life in infants born in Turkey.
Derya A; Necmi A; Emre A; Akgün Y
Am J Trop Med Hyg; 2005 Aug; 73(2):457-9. PubMed ID: 16103622
[TBL] [Abstract][Full Text] [Related]
2. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children.
Bell BP; Negus S; Fiore AE; Plotnik J; Dhotre KB; Williams J; Shapiro CN; McMahon BJ
Pediatr Infect Dis J; 2007 Feb; 26(2):116-22. PubMed ID: 17259872
[TBL] [Abstract][Full Text] [Related]
4. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up.
Sharapov UM; Bulkow LR; Negus SE; Spradling PR; Homan C; Drobeniuc J; Bruce M; Kamili S; Hu DJ; McMahon BJ
Hepatology; 2012 Aug; 56(2):516-22. PubMed ID: 22371069
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey.
Kaya D; Guler E; Ekerbicer HC; Dilber C; Karabiber H; Guler S; Davutoglu M; Ciragil P
J Viral Hepat; 2007 Dec; 14(12):830-4. PubMed ID: 18070285
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis a in Lebanon: a changing epidemiological pattern.
Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R
Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621
[TBL] [Abstract][Full Text] [Related]
8. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants.
Letson GW; Shapiro CN; Kuehn D; Gardea C; Welty TK; Krause DS; Lambert SB; Margolis HS
J Pediatr; 2004 Mar; 144(3):327-32. PubMed ID: 15001936
[TBL] [Abstract][Full Text] [Related]
9. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
13. Decline of maternal hepatitis A virus antibody levels in infants.
De Silvestri A; Avanzini MA; Terulla V; Zucca S; Polatti F; Belloni C
Acta Paediatr; 2002; 91(8):882-4. PubMed ID: 12222709
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.
Richardus JH; Vos D; Veldhuijzen IK; Groen J
J Med Virol; 2004 Feb; 72(2):197-202. PubMed ID: 14695660
[TBL] [Abstract][Full Text] [Related]
15. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
Joshi N; Yr NK; Kumar A
Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
[TBL] [Abstract][Full Text] [Related]
17. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A seroprevalence among infants aged 12 months in Ankara.
Ince OT; Yalçin SS; Yurdakök K; Ozmert EN
Turk J Pediatr; 2011; 53(1):114-6. PubMed ID: 21534354
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
